Sell-Side Advisory Research for Life Sciences and Pharma
Phronesis Partners provides research to support sell-side advisory engagements, helping sellers build a stronger evidence base around market positioning, competitive strengths, customer relationships and growth potential. Our M&A research can strengthen the commercial narrative presented to prospective buyers and help substantiate the assumptions underlying valuation and future performance.
For pharmaceutical and life sciences businesses, this can draw on our wider healthcare and life sciences market research capabilities to assess market conditions, stakeholder needs, competitive dynamics and commercial opportunities relevant to the transaction.
Sell-Side Advisory Research for Life Sciences and Pharma Transactions
Life science and pharma transactions often require potential buyers to understand not only historical performance, but also the commercial environment surrounding the business. Research can provide evidence on market attractiveness, customer and stakeholder needs, competitive positioning, growth opportunities and the assumptions supporting future performance.
For sellers, this evidence can help demonstrate where commercial value exists, address questions prospective buyers may raise and create a clearer, more defensible narrative around the business.
Sell-Side Advisory Research Approach and Methodology
Our sell-side advisory research is designed around the commercial questions prospective buyers are likely to examine. Depending on the transaction, the work can combine market sizing, competitor research, customer or stakeholder research, market landscape analysis and assessment of growth drivers.
The resulting evidence can help validate growth assumptions, identify key value drivers and address potential areas of buyer concern with credible market data. The objective is to strengthen the commercial case around the business while ensuring that claims about market potential and competitive position are supported by evidence.
Market Evidence for Life Science and Pharma Sell-Side Advisory
In life sciences and pharma sell-side advisory, the evidence required will depend on the company, product portfolio, market and transaction context. Research may need to assess market potential, competitor activity, stakeholder perceptions, unmet needs or future demand, helping sellers and their advisers understand which commercial factors are most relevant to the investment case.
Phronesis Partners can structure the research around the questions that need independent market evidence, complementing the financial and transaction work carried out by the seller’s wider advisory team.
Discuss Your Sell-Side Advisory Research Needs
Speak with our team about the market, customer, competitor or growth questions that need to be supported before a transaction. We can develop a focused research approach around the commercial evidence required for your sell-side process.
Discuss Your Sell-Side Research